Ergomed PLC (LON:ERGO) revealed that its pharmacovigilance division, PrimeVigilance, has signed a collaboration deal with Automation Anywhere, a leader in robotic process automation (RPA), and DataRobot, an enterprise artificial intelligence specialist, to accelerate its intelligent automation strategy.
AIM-listed Ergomed said PrimeVigilance had completed a proof of concept and will now implement a cloud software solution to automate specific pharmacovigilance processes.
READ: Ergomed to help run second trial in Italy targeting possible coronavirus treatments
The company noted that the productivity gains made possible by working with Automation Anywhere and DataRobot are expected to deliver organic growth more efficiently with the automation of manual, repetitive processes.
“Automation Anywhere's cloud-based RPA on its digital workforce platform combined with DataRobot's enterprise AI platform will bring new levels of speed and intelligence to a crucial component of the business”, Erogmed said in a statement, adding that the collaboration will also allow pharmacovigilance professionals to focus on “value creation and problem-solving that only humans can address”.
The firm also said the partnership will enhance its existing skills and expertise by “combining human insight and knowledge with the intelligent application of technology to enhance the speed and precision of analysis and decision making”.
"Adoption of the latest available technologies, including automation and robotic technology across our pharmacovigilance business, ensures we are able to continue to offer cutting edge services to our customers”, said Ergomed executive chairman Miroslav Reljanović.
“This collaboration provides the foundation to rapidly identify and automate a wide range of business processes, enabling clients to maximise quality and consistency within safety databases as well as increasing productivity", he added.